368 related articles for article (PubMed ID: 36230810)
21. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
22. Purinergic signaling in scarring.
Ferrari D; Gambari R; Idzko M; Müller T; Albanesi C; Pastore S; La Manna G; Robson SC; Cronstein B
FASEB J; 2016 Jan; 30(1):3-12. PubMed ID: 26333425
[TBL] [Abstract][Full Text] [Related]
23. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
24. Extracellular purines, purinergic receptors and tumor growth.
Di Virgilio F; Adinolfi E
Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
[TBL] [Abstract][Full Text] [Related]
25. Extracellular ATP signaling and clinical relevance.
Dou L; Chen YF; Cowan PJ; Chen XP
Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
[TBL] [Abstract][Full Text] [Related]
26. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
[TBL] [Abstract][Full Text] [Related]
27. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Dwyer KM; Kishore BK; Robson SC
Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
[TBL] [Abstract][Full Text] [Related]
28. Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities.
Wang P; Jia J; Zhang D
JHEP Rep; 2020 Dec; 2(6):100165. PubMed ID: 33103092
[TBL] [Abstract][Full Text] [Related]
29. The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk.
Adinolfi E; De Marchi E; Grignolo M; Szymczak B; Pegoraro A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762206
[TBL] [Abstract][Full Text] [Related]
30. Purinergic signaling in B cells.
Przybyła T; Sakowicz-Burkiewicz M; Pawełczyk T
Acta Biochim Pol; 2018; 65(1):1-7. PubMed ID: 29360885
[TBL] [Abstract][Full Text] [Related]
31. Impact of ectonucleotidases in autonomic nervous functions.
Cardoso AM; Schetinger MR; Correia-de-Sá P; Sévigny J
Auton Neurosci; 2015 Sep; 191():25-38. PubMed ID: 26008223
[TBL] [Abstract][Full Text] [Related]
32. Curcumin modulates purinergic signaling and inflammatory response in cutaneous metastatic melanoma cells.
Manica D; da Silva GB; Narzetti RA; Dallagnoll P; da Silva AP; Marafon F; Cassol J; de Souza Matias L; Zamoner A; de Oliveira Maciel SFV; Moreno M; Bagatini MD
Purinergic Signal; 2024 May; ():. PubMed ID: 38801619
[TBL] [Abstract][Full Text] [Related]
33. Adenosine and adenosine receptors in colorectal cancer.
Hajizadeh F; Masjedi A; Heydarzedeh Asl S; Karoon Kiani F; Peydaveisi M; Ghalamfarsa G; Jadidi-Niaragh F; Sevbitov A
Int Immunopharmacol; 2020 Oct; 87():106853. PubMed ID: 32755765
[TBL] [Abstract][Full Text] [Related]
34. Purinergic receptors in gastrointestinal inflammation.
Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
[TBL] [Abstract][Full Text] [Related]
35. Purines, purinergic receptors, and cancer.
Di Virgilio F
Cancer Res; 2012 Nov; 72(21):5441-7. PubMed ID: 23090120
[TBL] [Abstract][Full Text] [Related]
36. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
[TBL] [Abstract][Full Text] [Related]
37. Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy.
de Leve S; Wirsdörfer F; Jendrossek V
Front Immunol; 2019; 10():698. PubMed ID: 31024543
[TBL] [Abstract][Full Text] [Related]
38. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
39. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
40. Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile.
Merz J; Nettesheim A; von Garlen S; Albrecht P; Saller BS; Engelmann J; Hertle L; Schäfer I; Dimanski D; König S; Karnbrock L; Bulatova K; Peikert A; Hoppe N; Hilgendorf I; von Zur Mühlen C; Wolf D; Groß O; Bode C; Zirlik A; Stachon P
Purinergic Signal; 2021 Sep; 17(3):481-492. PubMed ID: 34282551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
